CHAPTER-I MYOCARDIAL INFARCTION

Similar documents
Acute coronary syndromes

Results of Ischemic Heart Disease

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction

Angina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room

When the learner has completed this module, she/he will be able to:

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

AIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection

FastTest. You ve read the book now test yourself

Anticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Coronary Artery Disease & Acute Coronary Syndrome

Diagnosis and Management of Acute Myocardial Infarction

MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient

Angina Pectoris Dr. Shariq Syed

Heart Disease (Coronary Artery Disease)

Acute Coronary Syndrome. Sonny Achtchi, DO

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Coronary Artery Disease

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016

Ischemic heart disease

Acute Coronary Syndrome


California Cardiovascular Consultants Medical Associates

BLOOD PRESSURE. Unit 3: Transportation and Respiration

Steps Against Recurrent Stroke (STARS)

Management of Acute Myocardial Infarction

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Drug Treatment of Ischemic Heart Disease

12 Lead EKG Chapter 4 Worksheet

Objectives. Treatment of ACS. Early Invasive Strategy. UA/NSTEMI General Concepts. UA/NSTEMI Initial Therapy/Antithrombotic

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Drug Treatment of Ischemic Heart Disease

Steps Against Recurrent Stroke (STARS)

Blood Thinner Agent. Done by: Meznah Al-mutairi Pharm.D Candidate PNU Collage of Pharmacy

Treatment of T Angina reatment of By Ali Alalawi

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

2008, American Heart Association. All rights reserved.

CORONARY ARTERY DISEASE OVERVIEW

COAGULATION, BLEEDING, AND TRANSFUSION IN URGENT AND EMERGENCY CORONARY SURGERY

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Oral Anticoagulant Drugs

APPENDIX F: CASE REPORT FORM

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

Index. Hematol Oncol Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

CHAPTER 17 Antithrombotic Agents Heparins

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Chp. 5 The cardiovascular system. What are the function of the cardiovascular system? Arteries and arterioles:

CORONARY ARTERY BYPASS GRAFT

Quinn Capers, IV, MD

Structure and organization of blood vessels

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)

Cardiovascular System Notes: Heart Disease & Disorders

Nitroglycerin and Heparin Drip Interfacility Protocols

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Continuing Medical Education Post-Test

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

all about your heart...

Hemostasis and Blood Forming Organs

Cardiovascular Concerns in Intermediate Care

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction

Chapter 2 ~ Cardiovascular system

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Appendix: ACC/AHA and ESC practice guidelines

QUT Digital Repository:

Index. Note: Page numbers of article titles are in boldface type.

AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE

THE CARDIOVASCULAR SYSTEM-PART 2

MYOCARDIALINFARCTION. By: Kendra Fischer

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Managing IHD and acute Myocardial Infarction

- Mohammad Sinnokrot. -Ensherah Mokheemer. - Malik Al-Zohlof. 1 P a g e

Guide to Cardiology Care at Scripps

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017

2010 ACLS Guidelines. Primary goals of therapy for patients

Acute Coronary Syndromes

Myocardial infarction

Atherosclerosis. Atherosclerosis happens when the blood vessels

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Myocardial Infarction In Dr.Yahya Kiwan

THROMBOTIC DISORDERS: The Final Frontier

Hypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union

Cindy Stephens, MSN, ANP Kelly Walker, MS, ACNP Peter Cohn, MD, FACC

CRITICAL REVIEW IN PHARMACEUTICAL SCIENCES eissn Review Article

Intravenous Infusions

Chapter / Section / Drug

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.

Management of Patients With Coronary Vascular Disorders

Agents for Peripheral Vascular Disease & Thrombosis

Agents for Peripheral Vascular Disease & Thrombosis

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Acute coronary syndrome (ACS) is an

Transcription:

CHAPTER-I MYOCARDIAL INFARCTION

Definition A myocardial infarction, more commonly known as MI or acute myocardial infarction (AMI) or heart attack is a condition where there is interruption of blood supply to a part of the heart

PATHOPHYSIOLOGY

Clinical Presentation P J,, S Nausea, S H and/or A (more U G N A S

DIAGNOSIS Physical Examination: Pallor, diaphoresis, tachycardia, S4, dyskinetic cardiac impulse may be present. If CHF exists, rales and S3 are present. Jugular venous distention is common in right ventricuqlar infarction. ECG : ST elevation, followed by T-wave inversion, then Q-wave development over several hours Non-ST Elevation MI, or NSTEMI ST depression followed by persistent ST-Twave changes without Q-wave development. Cardiac Biomarkers Cardiac-specific troponins T and I are highly specific for myocardial injury and are the preferred biochemical markers for diagnosis of MI

C Heart failure Ventricular fibrillation

R High Blood Cholesterol (Hyperlipidemia). Diabetes (Diabetes Mellitus). Male Gender Family History of Heart Disease. High Blood Pressure (Hypertension). Smoking or tobacco use

TREATMENT

Nonpharmacological treatment Keep your blood pressure, blood sugar, and cholesterol under control. Don't smoke. Eat a heart healthy diet rich in fruits, vegetables, and whole grains, and low in animal fat. Get plenty of exercise, at least 30 minutes a day, at least 5 days a week. Get checked and treated for depression. Limit yourself to no more than one drink a day for women, and no more than two drinks a day for men. Stay at a healthy weight. Aim for a body mass index (BMI) of between 18.5 and 24.9.

Antiplatelet and antithrombotic therapy Aspirin Clopidogrel Ticlopidine Unfractioned heparin Low molecular weight heparin (e.g. enoxaparin, dalteparin, tinzaparin) GPIIb/IIIa inhibitors

Fibrinolytic therapy Streptokinase Alteplase Reteplase Tenecteplase

Analgesics Morphine sulfate IV Nitroglycerine

Beta blockers Propranolol Metaprolol Atenolol

Other therapies ACE inhibitors Calcium channel blockers Amiodarone Lidocaine

Antiplatelets Aspirin has an antiplatelet effect which inhibits formation of further thrombi (blood clots) that clog arteries. An antiplatelet drug (antiaggregant) is a member of a class of pharmaceuticals that decrease platelet aggregation andinhibit thrombus formation.

Heparin Heparin binds to the enzyme inhibitor antithrombin III (AT). The activated AT then inactivates thrombin and other proteases involved in blood clotting, most notably factor Xa. The rate of inactivation of these proteases by AT can increase by up to 1000-fold due to the binding of heparin It produces its major anticoagulant effect by inactivating thrombin and activated factor X (factor Xa) through an antithrombin (AT)-dependent mechanism. Heparin binds to AT through a high-affinity pentasaccharide, which is present on about a third of heparin molecules. For inhibition of thrombin, heparin must bind to both the coagulation enzyme and AT, whereas binding to the enzyme is not required for inhibition of factor Xa.

GPIIb/IIIa antagonists GPIIb/IIIa antagonists. Platelet GPIIb/IIIa inhibitors block the final pathway of platelet aggregation

Fibrinolytic agent Improve myocardial oxygen supply by dissolving coronary thrombus, reestablishing blood flow to ischemic myocardium. Prompt therapy limits infarct size and improves survival

Morphine sulphate Reduce myocardial oxygen demand By causing pheripheral arterial dilatation that decrease systemic vasular resistance and afterload, circulating concentration of catecholamine

Nitroglycerin Nitroglycerin under the tongue or buccally can be given is useful to alleviate chest pain. The Glyceryl Trinitrate acts as a nitric oxide donor to smooth muscles cells adjacent to the coronary artery endothelium resulting in increased vasodilation and increased coronary blood flow.

Beta blockers β-blockers decrease the effect of the sympathetic nervous system on the heart. Since it is known that the sympathetic nervous system increases the heart rate and blood pressure in order to increase the cardiac output. Hence its blockage spares the heart the extra work load.

EMERGENCY TREATMENTS Angioplasty is a procedure to open narrowed or blocked blood vessels that supply blood to the heart. Usually a small, metal mesh tube called a stent is placed at the same time. Angioplasty is often the first choice of treatment. It should be done within 90 minutes after you get to the hospital, and no later than 12 hours after a heart attack.

A stent is a small, metal mesh tube that opens up (expands) inside a coronary artery. A stent is often placed after angioplasty. It helps prevent the artery from closing up again. Some patients may also have heart bypass surgery to open narrowed or blocked blood vessels that supply blood to the heart. This procedure is also called open heart surgery.